Dr Alessandra Rosenthal Laboratoire Central d’Immunologie

Slides:



Advertisements
Présentations similaires
Bratec Martin ..
Advertisements

NOTIFICATION ÉLECTRONIQUE
Fragilité : une notion fragile ?
SEMINAIRE DU 10 AVRIL 2010 programmation du futur Hôtel de Ville
Phono-sémantique différentielle des monosyllabes italiens
MAGGIO 1967 BOLOGNA - CERVIA ANOMALIES DU SOMMEIL CHEZ L'HOMME
droit + pub = ? vincent gautrais professeur agrégé – avocat
Transcription de la présentation:

Dr Alessandra Rosenthal Laboratoire Central d’Immunologie Le Complément Dr Alessandra Rosenthal Laboratoire Central d’Immunologie (Prof. A. Bernard) CHU de Nice

Système Immunitaire Immunité naturelle Immunité acquise

Immunité Naturelle Composants cellulaires : Cellules phagocytaires (neutro, mono, macrophages) Cellules relarguant des médiateurs (baso, eosino, mast cells) Cellules NK Composants moléculaires : Complément Protéines de la phase aïgue Cytokines (IFN etc)

Les trois voies d’activation du Complément Voie Initiateurs Classique Immuno-complexes Cellules apoptotiques Certains virus et bacteries Gram- CRP liée au ligand des lectines Microorganismes avec groupements mannoses terminaux Alterne Bactéries, champignons, virus, cellules tumorales

Activation du Complément Walport NEJM 2001

Assembly of C1 during the Classical Complement Pathway The Fab of IgG or IgM bind to epitopes on an antigen. C1q, C1r, and C1s then assembles on the Fc portion of the antibodies to form C1, the first enzyme of the classical complement pathway. The enzyme C1 is able to cleave C4 into C4a and C4b, as well as C2 into C2a and C2b.

Formation of C3 Convertase during the Classical Complement Pathway The enzyme C1 is able to cleave C4 into C4a and C4b. The C4b binds to adjacent proteins and carbohydrates on the surface of the antigen. C2 then binds to the C4b and C1 cleaves C2 into C2a and C2b. The C4a2b functions as a C3 convertase that can subsequently cleave hundreds of molecules of C3 and C3b.

Formation of C5 Convertase during the Classical Complement Pathway The C4a2b functions as a C3 convertase that can subsequently cleave hundreds of molecules of C3 into C3a and C3b. Much of the C3b binds to adjacent proteins and carbohydrates on the antigen to participate in opsonization while C3a can stimulate inflammatory responses. Some of the C3b binds to C4b2a to form C4b2a3b, a C5 convertase that can cleave C5 into C5a and C5b.

The Membrane Attack Complex (MAC) Causing Cell Lysis This C5b6789 membrane attack complex (MAC), puts pores into lipid bilayer membranes of human cells to which antibodies have bound. This results in cell lysis. MAC can also damage the envelope of enveloped viruses and put pores in the outer membrane and cytoplasmic membrane of gram-negative bacteria causing their lysis

Activation of the alternative complement pathway and formation of C3 convertase Activation of the alternative complement pathway begins when C3b (or C3i) binds to the cell wall and other surface components of microbes. Alternative pathway protein Factor B then combines with the cell-bound C3b to form C3bB. Factor D then splits the bound Factor B into Bb and Ba, forming C3bBb. A serum protein called properdin then binds to the Bb to form C3bBbP that functions as a C3 convertase capable of enzymatically splitting hundreds of molecules of C3 into C3a and C3b.

Formation of C5 convertase during the alternative complement pathway                                            Formation of C5 convertase during the alternative complement pathway     Some of the C3b subsequently binds to some of the C3bBb to form C3bBb3b, a C5 convertase capable of enzymatically splitting hundreds of molecules of C5 into C5a and C5b

Régulation du clivage of C3 par le Factor H et Factor I Walport NEJM 2001

Les trois principales activités physiologiques du système complémentaire Activité Protéines responsables Défense contre les infections : Opsonisation C3 et C4 Chimiotactisme et activation Anaphylotoxines (C5a, C3a et C4a) Lyse des bactéries et des cellules MAC (C5b-C9) Interface entre immunité naturelles et spécifique : Augmentation de la réponse Ab C3b et C4b liés aux CI; C3R sur B et APC Potentialisation de la mémoire Imm. C3b et C4b liés aux CI; C3R sur FDC Élimination des cellules endommagées: Clearance des CI dans les tissus C1q; fragments de C3 et C4 Clearance des cellules apoptotiques C1q; fragments de C3 et C4

Opsonization of a Bacterium The Fab portion of IgG binds to epitopes of an antigen. The Fc portion can now attach the antigen to Fc receptors on phagocytes for enhanced attachment. This is especially important against encapsulated microbes. C3b and C4b from the complement pathways can also attach antigens to phagocytes. Once attached to the phagocyte by way of IgG, C3b, or C4b, the microbe can be engulfed more efficiently and placed in a phagosome. As lysosomes fuse with the phagosome the microbe is digested.

Extracellular Killing After Opsonization . The Fab portions of IgG or C3b bind to epitopes on human cells recognized as foreign, such as virus-infected cells, tumor cells, or cells involved in autoimmune reactions. This enables phagocytes to attach to the cell by way of their Fc and C3b receptors. The phagocytes now destroy the cell by discharging their lysosomal contents

Chemotactict effect of C5a and C3b                                     Most C3b binds to antigens on the microbial surface. Some C3b combines with C2a and C4b to form the third enzyme of the complement pathway that is able to split C5 into C5a and C5b. C5a stimulates mast cells to release histamine for inflammation and diapedesis. It also functions as a chemoattractant for phagocytes. The phagocytes are then able to bind to the C3b attached to the surface of the microorganism allowing for opsonization (enhanced attachement)

Récepteurs du complément Nom Ligand(s) Distribution Fonction CR1 (CD35)  iC3b, C4b    B, phagocytes, GR, CFD       élimination des CI liés aux GR                                                     opsonisation                                                                         activation B CR2 (CD21) iC3b, C3dg     B, cellules epitheliales         activation B réc. EBV                                                                                                                       CR3 (CD11b/CD18) iC3b, ICAM-1      Phagocytes, NK CFD             Opsonine, lectine,                                                      adhesion molecule CR4 (CD11c/CD18) iC3b   Phagocytes          molécule d’adhésion opsonisation

Effets cliniques des principaux déficits héréditaires du Complément Déficit Conséquences sur l’act. du C’ Associations cliniques C3 incapacité d’opsonisation Infections à pyogènes incapacité à activer le MAC GN membrano-proliférative C3 Properdine incapacité à former le MAC Infections à Neisseria MAC C1q, C1r, incapacité à activer la voie LES C4, C2 classique

Pathologie du complément - anomalies de régulation Anomalie Clinique Ethiopathogénèse C3 nef - Glomérulonéphrite Auto-Ab qui stabilise le C3bBb membrano-proliférative Déficit en facteur H, I - Glomérulonéphrite Défaut de régulation de l’activation membrano-proliférative de C3, avec inflammation chronique - Syndr. Hémolyt. Urém. dans le glomérule et déficit secondaire en C Déficit en C1 inhibiteur - Oedème angioneurotique Défaut de la sérine-protéase qui inactive le C1 et le système de kinines-bradikinines Hémoglobinurie paroxystique - Hémolyse intravasculaire Déficit de régulation du MAC par nocturne défaut d ’expression des molécules GPI (CD55 et CD59)